RJFSA
AMPH icon

Raymond James Financial Services Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Raymond James Financial Services Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$462K Sell
9,517
-872
-8% -$38.3K ﹤0.01% 2677
2024
Q2 		$416K Buy
10,389
+1,505
+17% +$62.4K ﹤0.01% 2666
2024
Q1 		$390K Buy
+8,884
New +$459K ﹤0.01% 2697

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial Services Advisors's AMPH Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Amphastar Pharmaceuticals (AMPH) stake by 8.4% in Q3 2024, selling an estimated $38.3K and leaving 9,517 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

Raymond James Financial Services Advisors first reported a position in AMPH in Q1 2024 and has held it in 3 quarters since. 279 funds tracked by Wall St. Rank hold AMPH as of Q3 2024.

  • Raymond James Financial Services Advisors held 9,517 shares of Amphastar Pharmaceuticals worth $462K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 872 Amphastar Pharmaceuticals shares in Q3 2024, an estimated $38.3K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2677 holding.
  • Raymond James Financial Services Advisors first reported a position in Amphastar Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • 279 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.